By Will Soutter
Research and Markets has included a new report from Elsevier Science and Technology, titled ‘Nanobiotechnology, Vol 4. Inorganic Nanoparticles vs Organic Nanoparticles,’ to its catalogue.
Nanotechnology is expected to transform the biology and medicine fields. Over the last two decades, researchers have been working on the advancement of new biotechnology applications of innovative nanomaterials.
Nanomaterials are also gaining significance in medical applications, with the development of nanotechnology-based diagnostic tools and drugs. Hundreds of novel ideas based on nanomaterials are implemented in biosensor development every year and more number of companies is seeking market potential based on these technologies. Applications of nanomaterials in the biotechnological field are highly complex. A wide variety of nanoparticles shows potential for these applications. Some of these nanomaterials have a drastic difference in their potentiality, characterization and synthesis.
The comprehensive report is helpful to researchers seeking solutions in nanotechnology by helping them understanding which type of nanomaterials will be suitable for their requirements. It demonstrates the benefits and drawbacks of various types of nanomaterials, with special focus on the variations, benefits and drawbacks of organic nanoparticles versus inorganic nanoparticles for biotechnological and nanomedicine applications.
Key topics covered in the report include Chapter 1.-Synthesis and Characterization of Nanoparticles; Chapter 2.-Biotechnological Applications; Chapter 3.-Applications in Diagnostics and Biosensing; Chapter 4.- Nanoparticles for Therapy; and Chapter 5.-Toxicity and Regulation.